Novel carriers for coenzyme Q10 delivery

Current Drug Delivery

Volumn 13, Issue 8, 2016, Pages 1184-1204

  Kumar, Sunil ^a   Rao, Rekha ^a   Kumar, Anil ^a   Mahant, Sheefali ^b   Nanda, Sanju ^b  

^a GURU JAMBHESHWAR UNIVERSITY OF SCIENCE AND TECHNOLOGY   (India)

^b MAHARSHI DAYANAND UNIVERSITY   (India)

Author keywords

Coenzyme Q10; Drug delivery; Nanoformulations; Novel carriers; Nutraceuticals; Pharmacokinetics

Indexed keywords

DRUG CARRIER; LIPOSOME; NANOMATERIAL; NANOPARTICLE; POLYMER; SOLID LIPID NANOPARTICLE; UBIDECARENONE; ANTIOXIDANT; UBIQUINONE;

AQUEOUS SOLUTION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG POTENCY; DRUG SOLUBILITY; HUMAN; MICELLE; MOLECULAR WEIGHT; NANOEMULSION; NANOTECHNOLOGY; NONHUMAN; PRIORITY JOURNAL; REVIEW; ANALOGS AND DERIVATIVES; ANIMAL; CHEMISTRY;

ANIMALS; ANTIOXIDANTS; DRUG CARRIERS; DRUG COMPOUNDING; HUMANS; UBIQUINONE;

EID: 84995948064     PISSN: 15672018     EISSN: 18755704     Source Type: Journal    
DOI: 10.2174/1567201813666160104130631     Document Type: Review

References (130)

1. Collins, M.D.; Jones, D. Distribution of isoprenoid quinone structural types in bacteria and their taxonomic implication. Microbiol. Rev., 1981, 45(2), 316-354
2. Beg, S.; Javed, S.; Kohli, K. Bioavailability enhancement of coenzyme Q10: An extensive review of patents. Recent. Pat. Drug Deliv. Formul., 2010, 4(3), 245-257
3. Villalba, J.M.; Parrado, C.; Santos-Gonzalez, M.; Alcain, F.J. Therapeutic use of coenzyme Q10 and coenzyme Q10-related compounds and formulations. Expert Opin. Investig. Drugs, 2010, 19(4), 535-554
4. Folkers, K.; Wolaniuk, A.; Vadhanavikit, S.; Sakmato, N.; Takemura, K.; Baker, L.; Richardson, P.C. In: Biomedical and Clinical Aspects of Coenzyme Q; Folkers, K., Yamamura, Y., Eds.; Elsevier: Amsterdam, 1986, 5, pp. 375-391
5. Aberg, F.; Appelqvist, E.L.; Dallner, G.; Ernster, L. Distribution and redox state of ubiquinones in rat and human tissues. Arch. Biochem. Biophys., 1992, 295(2), 230-234
6. Swarnakar, N.K.; Thanki, K.; Jain, S. Lyotropic liquid crystalline nanoparticles of CoQ10: implication of lipase digestibility on oral bioavailability, in vivo antioxidant activity, and in vitro-in vivo relationships. Mol. Pharm., 2014, 11(5), 1435-1449
7. Garrido-Maraver, J.; Cordero, M.D.; Oropesa-Avila, M.; Vega, A.F.; Mata, M.; Pavon, A.D.; Miguel, M.; Calero, C.P.; Paz, M.V.; Cotan, D.; Sanchez-Alcazar, J.A. Coenzyme Q10 therapy. Mol. Syndromol., 2014, 5(3-4), 187-197
8. Gingold, E.B.; Kopsidas, G.; Linnane, A.W. Coenzyme Q10 and its putative role in the ageing process. Protoplasma, 2000, 214(1), 24-32
9. Aeby, A.; Sznajer, Y.; Cave, H.; Rebuffat, E.; Van Coster, R.; Rigal, O.; Van Bogaert, P. Cardiofaciocutaneous (CFC) syndrome associated with muscular coenzyme Q10 deficiency. J. Inhert. Matab. Dis., 2007, 30(5), 827-827
10. Dhanasekaran, M.; Ren, J. The emerging role of Coenzyme Q-10 in aging, neurodegeneration, cardiovascular disease, cancer and diabetes mellitus. Curr. Neurovasc. Res., 2005, 2(5), 1-13
11. Palamakula, A. Biopharmaceutical classification and development of limonene-based self-nanoemulsified capsule dosage form of coenzyme Q10. PhD Thesis, Texas Tech. University: Lubbock, May 2004
12. Kommuru, T.R.; Gurley, B.; Khan, M.A.; Reddy, I.K. Selfemulsifying drug delivery systems (SEDDS) of coenzyme Q10: Formulation development and bioavailability assessment. Int. J. Pharm., 2001, 212(2), 233-246
13. Parkhideh, D. Methods and compositions that enhance bioavailability of coenzyme-Q10. U.S. Patent 20,090,054,530, A1, February 26, 2009
14. Parkhideh, D. Methods and compositions that enhance bioavailability of coenzyme-Q10. U.S. Patent 7,438,903 B2, October 21, 2008
15. Doney, J.A; Olsen, S.; Shores, C.S. Benzoquinones of enhanced bioavailability. W.O. Patent 20, 07,014,392, A3, June 21, 2007
16. Olsen, S.; Doney, J.A.; Shores, C.S. Benzoquinone of enhanced bioavailability. U.S. Patent 2,00,70,026,072, A1, February 1, 2007
17. Rosenberg, J.; Breitenbach, J. Stable dosage forms containing ubiquinones. U.S. Patent 7,273,624, B2, September 25, 2007
18. Madhavi, D.L.; Kagan, D.I. Highly bioavailable coenzyme Q-10 cyclodextrin complex. U.S. Patent 7,030,102, B1, April 18, 2006
19. Minemura, T.; Kubota, H.; Takagi, S.; Nishizawa, Y. Composition comprising ubiquinone. U.S. Patent 7,026,361 B2, April 11, 2006
20. Ueda, T.; Ono, T.; Moro, M.; Kitamura, S.; Ueda, Y. Method of stabilising reduced coenzyme Q10. U.S. Patent application number 2005/, 008,630 A1, January 13, 2005
21. Chopra, R.K. Reduced form of coenzyme Q in high bioavailability stable oral dosage form. U.S. Patent 6,740,338 B1, May 25, 2004
22. Udell, R.G.; Hari, S.P. Super absorption coenzyme Q10. U.S. Patent 6,623,734, B2, September 23, 2003
23. Udel, R.G. Coenzyme Q10 formulation and process methodology for soft gel capsules manufacturing. U.S. Patent 6,616,942, B1, September 9, 2003
24. Chopra, R.K. Coenzyme Q products exhibiting high dissolution qualities. U.S. patent 6,300,377, B1, October 9, 2001
25. Ohashi, H.; Takami, T.; Koyama, N.; Kogure, Y.; Ida, K. Aqueous solution containing ubidecarenone. U.S. Patent 4,483,873, November 20, 1984
26. Chopra, R.K.; Goldman, R.; Sinatra, S.T.; Bhagavan, H.N. Relative bioavailability of coenzyme Q10 formulations in human subjects. Int. J. Vitam. Nutr. Res., 1998, 68(2), 109-113
27. Selzer, J. Co-enzyme Q10 dietary supplement. U.S. Patent 6,652,891, B2 November 25, 2003
28. Lenaz, G.; Fato, R.; Formiggini, G.; Genova, M.L. The role of coenzyme Q in mitochondrial electron transport. Mitochondrion., 2007, 7(Suppl), S8-S33
29. Boicelli, C.A.; Ramponi, C.; Casali, E.; Masotti, L. Ubiquinones: Stereochemistry and biological implications. Membr. Biochem., 1981, 4(2), 105-118
30. Borekova, M.; Hojerova, J.; Koprda, V.; Bauerova, K. Nourishing and health benefits of coenzyme Q10 a review. Czech J. Food Sci., 2008, 26(4), 229-241
31. Yoshida, H.; Kotani, Y.; Ochiai, K.; Araki, K. Production of ubiquinone-10 using bacteria. J. Gen. Appl. Microbiol., 1998, 44(1), 19-26
32. Okada, K.; Kainou, T.; Matsuda, H.; Kawamukai, M. Biological significance of the side chain length of ubiquinone in Saccharomyces cerevisiae. FEBS Lett., 1998, 431, 241-244
33. Xia, S.; Xu, S.; Zhang, X. Optimization in the preparation of coenzyme Q10 nanoliposomes. J. Agr. Food Chem., 2006, 54(17), 6358-6366
34. Zhang, J.; Wang, S. Topical use of coenzyme Q10-loaded liposomes coated with trimethyl chitosan: tolerance, precorneal retention and anti-cataract effect. Int. J. Pharm., 2009, 372(1-2), 66-75
35. Xia, S.; Xu, S.; Zhang, X.; Zhong, F.; Wang, Z. Nanoliposomes mediate coenzyme Q10 transport and accumulation across human intestinal Caco-2 cell monolayer. J. Agric. Food Chem., 2009, 57(17), 7989-7996
36. Lee, W.C.; Tsai, T.H. Preparation and characterization of liposomal coenzyme Q10 for in vivo topical application. Int. J. Pharm., 2010, 395(1-2), 78-83
37. Gokce, E.H.; Korkmaz, E.; Tuncay-Tanrıverdi, S.; Dellera, E.; Sandri, G.; Bonferoni, M.C.; Ozer, O. A comparative evaluation of coenzyme Q10-loaded liposomes and solid lipid nanoparticles as dermal antioxidant carriers. Int. J. Nanomed., 2012, 7, 5109-5117
38. Xia, F.; Jin, H.; Zhao, Y.; Guo, X. Preparation of coenzyme Q10 liposomes using supercritical anti-solvent technique. J. Microencapsul., 2012, 29(1), 21-29
39. Shao, Y.; Yang, L.; Han, H. TPGS-chitosome as an effective oral delivery system for improving the bioavailability of coenzyme Q10. Eur. J. Pharm. Biopharm., 2015, 89, 339-346
40. Kwon, S.S.; Nam, Y.S.; Lee, J.S.; Ku, B.S.; Han, S.H.; Lee, J.Y.; Chang, I.S. Preparation and characterization of coenzyme Q10loaded PMMA nanoparticles by a new emulsification process based on microfluidization. Colloids. Surf. A Physicochem. Eng. Asp., 2002, 210, 95-104
41. Ankola, D.D.; Viswanad, B.; Bhardwaj, V.; Ramarao, P.; Kumar, M.N. Development of potent oral nanoparticulate formulation of coenzyme Q10 for treatment of hypertension: can the simple nutritional supplements be used as first line therapeutic agents for prophylaxis/ therapy? Eur. J. Pharm. Bioharm., 2007, 67(2), 361-369
42. Nehilla, B.J.; Bergkvist, M.; Popat, K.C.; Desai, T.A. Purified and surfactant-free coenzyme Q10-loaded biodegradable nanoparticles. Int. J. Pharm., 2008, 348(1-2), 107-114
43. Nehilla, B.J.; Allen, P.G.; Desai, T.A. Surfactant-free, drugquantumdot coloaded poly (lactide-co-glycolide) nanoparticles: towards multifunctional nanoparticles. ACS Nano., 2008, 2(3), 538-544
44. Swarnakar, N.K.; Jain, A.K.; Singh, R.P.; Godugu, C.; Das, M.; Jain, S. Oral bioavailability, therapeutic efficacy and reactive oxygen species scavenging properties of coenzyme Q10-loaded polymeric nanoparticles. Biomaterials, 2011, 32(28), 6860-6874
45. Devadasu, V.R.; Wadsworth, R.M.; Kumar, M.N.V. Protective effects of nanoparticulate coenzyme Q10 and curcumin on inflammatory markers and lipid metabolism in streptozotocininduced diabetic rats: a possible remedy to diabetic complications. Drug Deliv. Transl. Res., 2011, 1(6), 448-455
46. Sharma, A.; Soliman, G.M.; Al-Hajaj, N.; Sharma, R.; Maysinger, D.; Kakkar, A. Design and evaluation of multifunctional nanocarriers for selective delivery of coenzyme Q10 to mitochondria. Biomacromolecules, 2012, 13(1), 239-252
47. Uekaji, Y.; Onishi, M.; Nakata, D.; Terao, K.; Paananen, A.; Partanen, R.; Yoshii, H. Micelle formation of coenzyme Q10 with dipotassium glycyrrhizate using inclusion complex of coenzyme Q10 with γ-cyclodextrin. J. Phys. Chem. B, 2014, 118(139), 11480-11486
48. Liu, L.; Mao, K.; Wang, W.; Pan, H.; Wang, F.; Yang, M.; Liu, H. Kolliphor R HS 15 micelles for the delivery of coenzyme Q10: preparation, characterization, and stability. AAPS PharmSciTech., 2015 (published online ahead of print on 4 September 2015)
49. Bunjes, H.; Drechsler, M.; Koch, M.H.J.; Westesen, K. Incorporation of the model drug ubidecarenone into solid lipid nanoparticles. Pharm. Res., 2001, 18(3), 287-293
50. Wissing, S.A.; Muller, R.H.; Manthei, L.; Mayer, C. Structural characterization of Q10-loaded solid lipid nanoparticles by NMR spectroscopy. Pharm. Res., 2004, 21(3), 400-405
51. Farboud, S.E.; Nasrollahi, S.A.; Tabbakhi, Z. Novel formulation and evaluation of a Q10-loaded solid lipid nanoparticle cream: in vitro and in vivo studies. Int. J. Nanomed., 2011, 6, 611-617
52. Korkm, E.; Gokce, E.H.; Ozer, O. Development and evaluation of coenzyme Q10 loaded solid lipid nanoparticle hydrogel for enhanced dermal delivery. Acta Pharm., 2013, 63(4), 517-529
53. Hsu, C.H.; Cui, Z.; Mumper, R.J.; Jay, M. Preparation and characterization of novel coenzyme Q10 nanoparticles engineered from microemulsion precursors. AAPS Pharm. Sci. Tech., 2003, 4(3), E32
54. Teeranachaideekul, V.; Souto, E.B.; Junyaprasert, V.B.; Muller, R.H. Cetyl palmitate-based NLC for topical delivery of coenzyme (Q10) development, physicochemical characterization and in vitro release studies. Eur. J. Pharm. Biopharm., 2007, 67(1), 141-148
55. Shin, J.Y.; Shin, J.I.; Kim, J.S.; Yang, Y.S.; Hwang, Y.; Yang, J.S.; Shin, D.; Seo, J.H.; Jin, Y.S.; Park, Y.C.; Hwang, J.S.; Kweon, D.H. Assembly of coenzyme Q10 nanostructure resembling nascent discoidal high density lipoprotein particle. Biochem. Biophys. Res. Commun., 2009, 388(2), 217-221
56. Junyaprasert, V.B.; Teeranachaideekul, V.; Souto, E.B.; Boonme, P.; Muller, R.H. Q10-loaded NLC versus nanoemulsions: stability, rheology and in vitro skin permeation. Int. J. Pharm., 2009, 377(12), 207-214
57. Yue, Y.; Zhou, H.; Liu, G.; Li, Y.; Yan, Z.; Duan, M. The advantages of a novel CoQ10 delivery system in skin photo-protection. Int. J. Pharm., 2010, 392(1-2), 57-63
58. Liu, G.Y.; Wang, J.M.; Xia, Q. Application of nanostructured lipid carrier in food for the improved bioavailability. Eur. Food Res. Technol., 2012, 234(3), 391-398
59. Ok, H.; Kim, S.; Park, J.; Kim, K.; Nam, H.; Kim, J.Y.; Kwon, O. Development of nanoparticulate formulation of coenzyme Q10 and comparison of plasma coenzyme Q10 response in a single supplementation with regular coenzyme Q10 using rats. J. Korean Soc. Appl. Biol. Chem., 2012, 55(5), 619-623
60. Wang, J.; Wang, H.; Zhou, X.; Tang, Z.; Liu, G.; Liu, G.; Xia, Q. Physicochemical characterization, photo-stability and cytotoxicity of coenzyme Q10-loading nanostructured lipid carrier. J. Nanosci. Nanotechnol., 2012, 12(3), 2136-2148
61. Nanjwade, B.K.; Kadam, V.T.; Manvi, F.V. Formulation and characterization of nanostructured lipid carrier of ubiquinone (Coenzyme Q10). J. Biomed. Nanotechnol., 2013, 9(3), 450-460
62. Burge, F.; Damiani, E.; Puglia, C.; Offerta, A.; Armeni, T.; Littarru, G.P.; Tiano, L. Nanostructured lipid carriers loaded with CoQ10: Effect on human dermal fibroblasts under normal and UVA-mediated oxidative conditions. Int. J. Pharm., 2013, 455(12), 348-356
63. Schwarz, J.C.; Baisaeng, N.; Hoppel, M.; Low, M.; Keck, C.M.; Valenta, C. Ultra-small NLC for improved dermal delivery of coenyzme Q10. Int. J. Pharm., 2013, 447(1-2), 213-217
64. Lohan, S.B.; Bauersachs, S.; Ahlberg, S.; Baisaeng, N.; Keck, C.M.; Muller, R.H.; Witte, E.; Wolk, K.; Hackbarth, S.; Roder, B.; Lademann, J.; Meinke, M.C. Ultra-small lipid nanoparticles promote the penetration of coenzyme Q10 in skin cells and counteract oxidative stress. Eur. J. Pharm. Biopharm., 2015, 89(1), 201-207
65. Kommuru, T.R.; Gurley, B.; Khan, M.A.; Reddy, I.K. Selfemulsifying drug delivery systems (SEDDS) of coenzyme Q10: Formulation development and bioavailability assessment. Int. J. Pharm., 2001, 212(2), 233-246
66. Nazzal, S.; Smalyukh, I.I.; Lavrentovich, O.D.; Khan, M.A. Preparation and in vitro characterization of a eutectic based semisolid self-nanoemulsifying drug delivery system (SNEDDS) of ubiquinone: mechanism and progress of emulsion formation. Int. J. Pharm., 2002, 235(1-2), 247-265
67. Palamakula, A.; Khan, M.A. Evaluation of cytotoxicity of oils used in coenzyme Q10 Self-emulsifying Drug Delivery Systems (SEDDS). Int. J. Pharm., 2004, 273(1-2), 63-73
68. Balakrishanan, P.; Lee, B.J.; Oh, D.H.; Kim, J.O.; Lee, Y.I.; Kim, D.D.; Jee, J.P.; Lee, Y.B.; Woo, J.S.; Yong, C.S.; Choi, H.G. Enhanced oral bioavailability of coenzyme Q10 by self-emulsifying drug delivery systems. Int. J. Pharm., 2009, 374(1-2), 66-72
69. Nepal, P.R.; Han, H.; Choi, H. Preparation and in vitro-in vivo evaluation of witepsol® H35 based self-emulsifying drug delivery systems (SNEDDS) of coenzyme Q10. Eur. J. Pharm. Sci., 2010, 39(4), 224-232
70. Onoue, S.; Uchida, A.; Kuriyama, K.; Nakamura, T.; Seto, Y.; Kato, M.; Hatanaka, J.; Tanaka, T.; Miyoshi, H.; Yamada, S. Novel solid self-emulsifying drug delivery system of coenzyme Q10 with improved photochemical and pharmacokinetic behaviors. Eur. J. Pharm. Sci., 2012, 46(5), 492-499
71. Agrawal, A.G.; Kumar, A.; Gide, P.S. Formulation development and in vivo hepatoprotective activity of self nanoemulsifying drug delivery system of antioxidant coenzyme Q10. Arch. Pharm. Res., 2014, doi: 10.1007/s12272-014-0497-z
72. Carli, F.; Chiellini, E.E.; Bellich, B.; Macchiavelli, S.; Cadelli, G. Ubidecarenone nanoemulsified composite systems. Int. J. Pharm., 2005, 291(1-2), 113-118
73. Belhaj, N.; Dupuis, F.; Arab-Tehrany, E.; Denis, F.M.; Paris, C.; Lartaud, I.; Linder, M. Formulation, characterization and pharmacokinetic studies of coenzyme Q10 PUFA’s nanoemulsions. Eur. J. Pharm. Sci., 2012, 47(2), 305-312
74. Zhou, H.; Zheng, J.; Jin, Q.; Liu, G.; Long, Y.; Duan, M.; Xia, Q. Targeting of coenzyme Q10 via D-alpha-tocopheryl polyethylene glycol 1000 succinate-based nanoemulsion to the heart. Mater. Lett., 2013, 109, 20-22
75. Cheuk, S.Y.; Shih, F.F.; Champagne, E.T.; Daigle, K.W.; Patindol, J.A.; Mattison, C.P.; Boue, S.M. Nano-encapsulation of coenzyme Q10 using octenyl succinic anhydride modified starch. Food Chem., 2015, 174, 585-590
76. Bhandari, K.H.; Newa, M.; Kim, J.A.; Yoo, B.K.; Woo, J.S.; Lyoo, W.S.; Lim, H.T.; Choi, H.G.; Yong, C.S. Preparation, characterization and evaluation of coenzyme Q10 binary solid dispersions for enhanced solubility and dissolution. Biol. Pharm. Bull., 2007, 30(6), 1171-1176
77. Nepal, P.R.; Han, H.; Choi, H. Enhancement of solubility and dissolution of coenzyme Q10 using solid dispersion formulation. Int. J. Pharm., 2010, 383(1-2), 147-153
78. Onoue, S.; Terasawa, N.; Nakamura, T.; Yuminoki, K.; Hashimoto, N.; Yamada, S. Biopharmaceutical characterization of nanocrystalline solid dispersion of coenzyme Q10 prepared with cold wetmilling system. Eur. J. Pharm. Sci., 2014, 53, 118-125
79. Terao, K.; Nakata, D.; Fukumi, H.; Schmid, G.; Arima, H.; Hirayama, F.; Uekama, K. Enhancement of oral bioavailability of coenzyme Q10 by complexation with γ-cyclodextrin in healthy adults. Nutr. Res., 2006, 26(10), 503-508
80. Hatanaka, J.; Kimura, Y.; Lai-Fu, Z.; Onoue, S.; Yamada, S. Physicochemical and pharmacokinetic characterization of water-soluble coenzyme Q10 formulations. Int. J. Pharm., 2008, 363(1-2), 112-117
81. Nishimura, K.; Higashi, T.; Yoshimatsu, A.; Hirayama, F.; Uekama, K.; Arima, H. Pseudorotaxane-like supramolecular complex of coenzyme Q10 with γ-cyclodextrin formed by solubility method. Chem. Pharm. Bull., 2008, 56(5), 701-706
82. Higashi, T.; Nishimura, K.; Yoshimatsu, A.; Ikeda, H.; Arima, K.; Motoyama, K.; Hirayama, F.; Uekama, K.; Arima, H. Preparation of four types of coenzyme Q10/gamma-cyclodextrin supramolecular complexes and comparison of their pharmaceutical properties. Chem. Pharm. Bull., 2009, 57(9), 965-970
83. Yamaguchi, A.; Tozuka, Y.; Takeuchi, H. A combination processing for preparing CoQ10/ γ-CyD nanoparticles using both an ultra high pressure homogeniser and a pulse combustion dryer system. J. Soc. Powder Technol. Jpn., 2010, 47(11), 773-778
84. Siekmann, B.; Westesen, K. Preparation and physicochemical characterization of aqueous dispersions of coenzyme Q10 nanoparticles. Pharm. Res., 1995, 12(2), 201-208
85. Prosek, M.; Butinar, J.; Lukanc, B.; Fir, M.M.; Milivojevic, L.; Krizman, M.; Smidovnik, A. Bioavailability of water-soluble CoQ10 in beagle dogs. J. Pharm. Biomed. Anal., 2008, 47(4-5), 918-922
86. Zhou, H.; Yue, Y.; Liu, G.; Li, Y.; Zhang, J.; Yan, Z.; Duan, M. Characterization and skin distribution of lecithin-based coenzyme Q10-loaded lipid nanocapsules. Nanoscale Res. Lett., 2010, 5(10), 1561-1569
87. Piao, H.; Ouyang, M.; Xia, D.; Quan, P.; Xiao, W.; Song, Y.; Cui, F. In vitro-in vivo study of CoQ10-loaded lipid nanoparticles in comparison with nanocrystals. Int. J. Pharm., 2011, 419(1-2), 255-259
88. Kim, E.; Kim, J.; Chung, H.; Lim, S. Preparation of aqueous dispersions of coenzyme Q10 nanoparticles with amylomaize starch and its dextrin. LWT Food Sci. Technol., 2012, 47(2), 493-499
89. Sun, J.; Wang, F.; Sui, Y.; She, Z.; Zhai, W.; Wang, C.; Deng, Y. Effect of particle size on solubility, dissolution rate, and oral bioavailability: evaluation using coenzyme Q10 as naked nanocrystals. Int. J. Nanomed., 2012, 7, 5733-5744
90. Matsushita, N.; Oshima, T.; Takahashi, H.; Baba, Y. Enhanced water dispersibility of coenzyme Q10 by complexation with albumin hydrolysate. J. Agric. Food Chem., 2013, 61(25), 5972-5978
91. Zhou, H.; Zhang, J.; Long, Y.; Liu, G.; Duan, M.; Xia, Q. Improvement of the oral bioavailability of coenzyme Q10 with lecithin nanocapsules. J. Nanosci. Nanotechnol., 2013, 13(1), 706-710
92. Zhou, H.; Liu, G.; Zhang, J.; Sun, N.; Duan, M.; Yam, Z.; Xia, Q. Novel lipid-free nanoformulation for improving oral bioavailability of coenzyme Q10. Biomed. Res. Int., 2014, 1-9
93. Yoon, H.K.; Seo, T.R.; Lim, S.T. Stabilization of aqueous dispersion of CoQ10 nanoparticles using maize starches. Food Hydrocolloid., 2014, 35, 144-149
94. Yadav, N.K.; Nanda, S.; Sharma, G.; Katare, O.P. Systemically optimized coenzyme q10-loaded novel proniosomal formulation for treatment of photo-induced aging in mice: characterization, biocompatibility studies, biochemical estimations and anti-aging evaluation. J. Drug Target., 2015 (published online ahead of print on 24 August 2015)
95. Barakat, A.; Shegokar, R.; Dittgen, M.; Muler, R.H. Coenzyme Q10 oral bioavailability: effect of formulation type. J. Pharm. Invest., 2013, 43(6), 431-451
96. Verma, D.D.; Verma, S.; Blume, G.; Fahr, A. Particle size of liposomes influences dermal delivery of substances into skin. Int. J. Pharm., 2003, 258(1-2), 141-151
97. Hoppe, U.; Bergemann, J.; Diembeck, W.; Ennen, J.; Gohla, S.; Harris, I.; Jacob, J.; Kielholz, J.; Mei, W.; Pollet, D.; Schachtschabel, D.; Sauermann, G.; Schreiner, V.; Stab, F.; Steckel, F. Coenzyme Q10, a cutaneous antioxidant and energizer. Biofactors, 1999, 9(2-4), 371-378
98. Muta-Takada, K.; Terada, T.; Yamanishi, H.; Ashida, Y.; Inomata, S.; Nishiyama, T.; Amano, S. Coenzyme Q10 protects against oxidative stress-induced cell death and enhances the synthesis of basement membrane components in dermal and epidermal cells. Biofactors, 2009, 35(5), 435-441
99. Couvreur, P.; Vauthier, C. Polyalkylcyanoacrylate nanoparticles as drug carrier: present state and perspectives. J. Control. Release, 1991, 17(2), 187-198
100. Espuelas, M.S.; Legrand, P.; Irache, J.M.; Gamazo, C.; Orecchioni, A.M.; Devissaguet, J.; Ygartua, P. Poly(ε-caprolactone) nanospheres as an alternative way to reduce amphotericin B toxicity. Int. J. Pharm., 1997, 158, 19-27
101. Zambaux, M.F.; Bonneaux, F.; Gref, R.; Maincent, P.; Dellacherie, E.; Alonso, M.J.; Labrude, P.; Vigneron, C. Influence of experimental parameters on the characteristics of poly(lactic acid) nanoparticles prepared by double emulsion method. J. Control. Release., 1998, 50(1-3), 31-40
102. Jung, J.; Perrut, M. Particle design using supercritical fluids: Literature and patent survey. J. Supercrit. Fluids., 2001, 20(3), 179-219
103. Jain, A.K.; Swarnakar, N.K.; Godugu, C.; Singh, R.P.; Jain, S. The effect of the oral administration of polymeric nanoparticles on the efficacy and toxicity of tamoxifen. Biomaterials, 2011, 32(2), 503-515
104. Torchilin, V. Structure and design of polymeric surfactant-based drug delivery systems. J. Control. Release, 2001, 73(2-3), 137-172
105. Dhembre, G.N.; Moon, R.S.; Kshirsagar, R.V. A review on polymeric micellar nanocarriers. Int. J. Pharm. Bio. Sci., 2011, 2(2), 109-116
106. Joshi, M.D.; Muller, R.H. Lipid nanoparticles for parenteral delivery of actives. Eur. J. Pharm. Biopharm., 2009, 71(2), 161-172
107. Souto, E.B.; Severino, P.; Basso, R.; Santana, M.H. Encapsulation of antioxidants in gastrointestinal-resistant nanoparticulate carriers. Methods Mol. Biol., 2013, 1028, 37-46
108. Singh, B.; Bandopadhyay, S.; Kapil, R.; Singh, R.; Katare, O. Selfemulsifying drug delivery systems (SEDDS): formulation development, characterization, and applications. Crit. Rev. Ther. Drug Carrier Syst., 2009, 26(5), 427-521
109. Rao, S.; Tan, A.; Boyd, B.J.; Prestidge, C.A. Synergistic role of self-emulsifynig lipids and nanostructured porous silica particles in optimizing the oral delivery of lovastatin. Nanomedicine (Lond)., 2014, 9(18), 2745-2759
110. D'Souza, S.; Rosseels, V.; Denis, O.; Tanghe, A.; Smet, N. D.; Jurion, F.; Palfliet, K.; Castiglioni, N.; Vanonckelen, A.; Wheeler, C.; Huygen, K. Improved tuberculosis DNA vaccines by formulation in cationic lipids. Infect. Immun., 2002, 70(7), 3681-3688
111. Giri, T.K.; Kumar, K.; Alexander, A.; Ajazuddin Badwaik, H.; Tripathi, D.K. 2012. A novel and alternative approach to controlled release drug delivery system based on solid dispersion technique. B-FOPCU, 2012, 50(2), 147-159
112. Merkus, F.W.; Verhoef, J.C.; Marttin, E.; Romeijin, S.G.; van der Kuy, P.H.; Hermens, W.A.; Schipper, N.G. Cyclodextrins in nasal drug delivery. Adv. Drug. Deliv. Rev., 1999, 36(1), 41-57
113. Loftsson, T.; Magnusdottir, A.; Masson, M.; Sigurjonsdottir, J.F. Self-association and cyclodextrin solubilization of drugs. J. Pharm. Sci., 2002, 91(11), 2307-2316
114. Loftsson, T.; Duchene, D. Cyclodextrins and their pharmaceutical applications. Int. J. Pharm., 2007, 329(1-2), 1-11
115. Yang, H.Y.; Song, J.F. Inclusion of coenzyme Q10 with betacyclodextrin studied by polarography. Yao Xue Xue Bao, 2006, 41(7), 671-674
116. Vyas, S.P.; Khar, R.K. In: Controlled drug delivery concepts and advances. Vallabh Prakashan: New Delhi, 2002; pp. 54-96
117. Lyon, W.; Van den Brink, O.; Pepe, S.; Wowk, M.; Marasco, S.; Rosenfeldt, F.L. Similar therapeutic serum levels attained with emulsified and oil-based preparations of coenzyme Q10. Asia Pac. J. Clin. Nutr., 2001, 10(3), 212-215
118. Liu, Z.X.; Artmann, C. Relative bioavailability comparison of different coenzyme Q10 formulations with a novel delivery system. Altern. Ther. Health Med., 2009, 15(2), 42-46
119. Scalori, V.; Alessandri, M.G.; Mian, M.; Giovannini, L.; Bertelli, A.A. Plasma and tissue concentrations of coenzyme Q10 in the rat after its oral administration. Int. J. Tissue React., 1988, 10(2), 95-97
120. Hanisch, F.; Zierz, S. Only transient increase of serum CoQ subset 10 during long-term CoQ10 therapy in mitochondrial ophthalmoplegia. Eur. J. Med. Res., 2003, 8(11), 485-491
121. Joshi, S.S.; Sawant, S.V.; Shedge, A.; Halpner, A.D. Comparative bioavailability of two novel coenzyme Q10 preparations in humans. Int. J. Clin. Pharmacol. Ther., 2003, 41(1), 42-48
122. Bhagavan, H.N.; Chopra, R.K. Coenzyme Q10: absorption, tissue uptake, metabolism and pharmacokinetics. Free Radic. Res., 2006, 40(5), 445-453
123. Bhagavan, H.N.; Chopra, R.K. Plasma coenzyme Q10 response to oral ingestion of coenzyme Q10 formulations. Mitochondrion, 2007, 7(Suppl), S78-S88
124. Miles, M.V. The uptake and distribution of coenzyme Q10. Mitochondrion, 2007, 7(Suppl), S72-S77
125. Ochiai, A.; Itagaki, S.; Kurokawa, T.; Kobayashi, M.; Hirano, T.; Iseki, K. Improvement in intestinal coenzyme Q10 absorption by food intake. J. Pharm. Soc. Japan., 2007, 127(8), 1251-1254
126. Kalenikova, E.I.; Gorodetskaya, E.A.; Medvedev, O.S. Pharmacokinetics of coenzyme Q10. Bull. Exp. Biol. Med., 2008, 146(3), 313-316
127. Kalenikova, E.I.; Gorodetskaya, E.A.; Medvedev, O.S. Bioavailability of coenzyme Q10 in various pharmaceutical formulations. Pharm. Chem. J., 2009, 43(8), 468-471
128. Sato, Y.; Mutoh, H.; Suzuki, M.; Takekuma, Y.; Iseki, K.; Sugawara, M. Emulsification using highly hydrophilic surfactants improves the absorption of orally administered coenzyme Q10. Biol. Pharm. Bull., 2013, 36(12), 2012-2017
129. Kalenikova, E.I.; Kharitonova, E.V.; Gorodetskava, E.A.; Tokareva, O.G.; Medvedev, O.S. Rodox status and pharmacokinetics of coenzyme Q10 in rat plasma after its single intravenous administration. Biochem. (Mosc.) Suppl., Ser. B Biomed. Chem., 2014, 8(3), 267-272
130. Das, S.; Chaudhury, A. Recent advances in lipid nanoparticles formulations with solid matrix for oral drug delivery. AAPS Pharm-SciTech., 2011, 12(1), 62-76